EIF4A1
MOLECULAR TARGETeukaryotic translation initiation factor 4A1
EIF4A1 (eukaryotic translation initiation factor 4A1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting EIF4A1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | rocaglamide | 2.89 | 17 |
| 2 | hippuristanol | 2.20 | 8 |
| 3 | cycloheximide | 1.61 | 4 |
| 4 | Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). | 0.69 | 1 |
About EIF4A1 as a Drug Target
EIF4A1 (eukaryotic translation initiation factor 4A1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented EIF4A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
EIF4A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.